Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VERA Vera Therapeutics, Inc.

Not Yet Opened 06-25 16:00:00 EDT

40.50

+0.99

+2.51%

盘后43.43

+2.93+7.23%

19:59 EDT

High41.70	Low39.46	Vol2.89M
Open39.79	D1 Closing39.51	Amplitude5.66%
Mkt Cap2.90B	Tradable Cap2.03B	Total Shares71.71M
T/O117.76M	T/O Rate5.75%	Tradable Shares50.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VERA","market":"US","secType":"STK","nameCN":"Vera Therapeutics, Inc.","latestPrice":40.5,"timestamp":1782417600000,"preClose":39.51,"halted":0,"volume":2885349,"hourTrading":{"tag":"盘后","latestPrice":43.43,"preClose":40.5,"latestTime":"19:59 EDT","volume":253274,"amount":10313370.2182,"timestamp":1782431961994,"change":2.93,"changeRate":0.072346,"amplitude":0.074074},"delay":0,"changeRate":0.025056947608200507,"floatShares":50198200,"shares":71713905,"eps":-5.574565,"marketStatus":"Not Yet Opened","change":0.99,"latestTime":"06-25 16:00:00 EDT","open":39.79,"high":41.695,"low":39.46,"amount":117762518.67204,"amplitude":0.056568,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.574565,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782460800000},"marketStatusCode":0,"adr":0,"listingDate":1620964800000,"exchange":"NASDAQ","adjPreClose":39.51,"preHourTrading":{"tag":"盘前","latestPrice":37.01,"preClose":39.51,"latestTime":"08:27 EDT","volume":892,"amount":35646.030856,"timestamp":1782390421180,"change":-2.5,"changeRate":-0.063275,"amplitude":0.078714},"postHourTrading":{"tag":"盘后","latestPrice":43.43,"preClose":40.5,"latestTime":"19:59 EDT","volume":253274,"amount":10313370.2182,"timestamp":1782431961994,"change":2.93,"changeRate":0.072346,"amplitude":0.074074},"volumeRatio":1.627238,"impliedVol":1.1984,"impliedVolPercentile":0.896},"requestUrl":"/m/hq/s/VERA/tweets","defaultTab":"tweets","newsList":[{"id":"2646722846","title":"Vera Therapeutics CEO Marshall Fordyce Disposes of USD 702,065 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646722846","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646722846?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:56","pubTimestamp":1782334588,"startTime":"0","endTime":"0","summary":"Vera Therapeutics CEO Marshall Fordyce disposes of USD 702,065 in common sharesVera Therapeutics President and CEO Marshall Fordyce sold 18,500 Class A common shares on June 23.Shares sold at a weight","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDLCVnjM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vera Therapeutics CEO Marshall Fordyce Disposes of USD 702,065 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VERA","BK4539","BK4585","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644954537","title":"Vera Therapeutics (VERA) Stock After FDA Trial Update Has The Valuation Gap Gone Too Far","url":"https://stock-news.laohu8.com/highlight/detail?id=2644954537","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644954537?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:25","pubTimestamp":1781648725,"startTime":"0","endTime":"0","summary":"Vera Therapeutics (VERA) stock is in focus after the company reached agreement with the FDA on an earlier eGFR analysis for its ORIGIN 3 trial of atacicept in IgA nephropathy.\nSee our latest analysis for Vera Therapeutics.\nAt a share price of $34.24, Vera Therapeutics has seen the 7 day share price return rise 7.84%, although the 90 day share price return is down 12.92% and the year to date share price return is down 29.58%. The 1 year total shareholder return of 56.70% and 3 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vera/vera-therapeutics/news/vera-therapeutics-vera-stock-after-fda-trial-update-has-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vera/vera-therapeutics/news/vera-therapeutics-vera-stock-after-fda-trial-update-has-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","BK4585","VERA","LU2324357040.USD","BK4588","DCF","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642259595","title":"Vera Therapeutics (VERA) Receives a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2642259595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642259595?lang=en_us&edition=fundamental","pubTime":"2026-06-12 10:55","pubTimestamp":1781232912,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst maintained a Buy rating on Vera Therapeutics yesterday and set a price target of $70.00. In a report released on June 5, Goldma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vera-therapeutics-vera-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vera-therapeutics-vera-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930573.SGD","BK4539","LU0251142724.SGD","LU0868494708.USD","IE0002270589.USD","LU0130517989.USD","LU0787776722.HKD","LU0251131958.USD","LU0477156953.USD","LU1069347547.HKD","BK4139","LU2361044949.HKD","LU0310800965.SGD","BK4585","LU1074936037.SGD","LU0289960550.SGD","LU0310800379.SGD","LU0648001328.SGD","LU0256863811.USD","LU0175139822.USD","LU2236285917.USD","LU2361044865.SGD","IE00B19Z3581.USD","BK4559","LU0971096721.USD","LU0128525689.USD","LU1201861249.SGD","LU1894683348.USD","LU0070302665.USD","LU0417517546.SGD","PGF","LU0683600562.USD","LU0742534661.SGD","LU1814569148.SGD","LU2361045086.USD","LU1668664300.SGD","LU0106831901.USD","VERA","LU0130102774.USD","LU0310799852.SGD","LU0029864427.USD","LU0052756011.USD","LU0708994859.HKD","BK4504","LU1506573853.SGD","LU1894683264.USD","IE00B7SZLL34.SGD","LU2461242641.AUD","LU0162691827.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641414742","title":"Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641414742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641414742?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:05","pubTimestamp":1780689900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nTUA47YDGJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4585","VERA","LU2324357040.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641147236","title":"Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641147236","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641147236?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:05","pubTimestamp":1780689900,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., June  05, 2026  (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on June 2, 2026, the Compensation Committee of the Board of Directors (Compensation C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/05/3307602/0/en/Vera-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4539","LU2324357040.USD","VERA","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641442651","title":"Analysts’ Top Healthcare Picks: Vera Therapeutics (VERA), Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641442651","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641442651?lang=en_us&edition=fundamental","pubTime":"2026-06-06 02:01","pubTimestamp":1780682466,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vera Therapeutics (VERA), Johnson & Johnson (JNJ) an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-vera-therapeutics-vera-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-vera-therapeutics-vera-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU1061106388.HKD","LU1228905037.USD","LU0943347566.SGD","LU0070217475.USD","XLV","LU1732799900.SGD","LU0098860793.USD","LU1228905540.USD","LU2133065610.SGD","LABU","IE00B3T34201.USD","LU0234572021.USD","IE00BVYPNW00.USD","LU2403377893.USD","SG9999001440.SGD","LU0985320562.USD","LU1718418525.SGD","IE0002141913.USD","LU1066051811.HKD","LU1066053197.SGD","XBI","LU2456880835.USD","IE000F7OJYX1.SGD","LU0912757837.SGD","BK4592","BK4533","BK4534","LU1551013425.SGD","LU2430703095.HKD","LU1629891620.HKD","LU0122379950.USD","LU1221951046.USD","IE00BFXG1179.USD","IE000WAW04H5.SGD","LU1280957306.USD","LU0889566641.SGD","LU1066051225.USD","LU0320765646.SGD","LU2430703178.SGD","LU2750360997.AUD","SG9999013999.USD","LU2487616109.SGD","VERA","IE000SO60NU8.SGD","LU1121112475.USD","IE0002270589.USD","LU2129689514.USD","JNJ","IE000BZT7R73.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641145811","title":"Vera Therapeutics posts atacicept IgA nephropathy trial presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2641145811","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641145811?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:13","pubTimestamp":1780654429,"startTime":"0","endTime":"0","summary":"Vera Therapeutics published a medical research presentation on atacicept in IgA nephropathy, spanning ORIGIN 3 subgroup results, PIONEER IgAN early data, and ORIGIN EXTEND off-treatment findings.ORIGIN 3 interim data: atacicept met the Week 36 primary endpoint, cutting 24-hour UPCR 46% vs baseline versus 7% on placebo; 42% vs placebo , p<0.001.Proteinuria benefit held across key subgroups, including baseline UPCR below or above 1 g/g, baseline eGFR below or above 45 mL/min/1.73 m2.Secondary markers improved at Week 36, including Gd-IgA1 down 68% and hematuria resolution in 81% of participants.Safety update from a May 15, 2025 interim cut: adverse events broadly balanced; serious adverse events 0.5% on atacicept versus 5% on placebo; no deaths.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL7ZjPLw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2324357040.USD","BK4539","VERA","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641161735","title":"Otsuka says kidney disease drug preserves function in late-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2641161735","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641161735?lang=en_us&edition=fundamental","pubTime":"2026-06-05 02:37","pubTimestamp":1780598229,"startTime":"0","endTime":"0","summary":"Otsuka says kidney disease drug preserves function in late-stage studyBy Siddhi Mahatole and Sriparna Roy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nL4N42C1KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2362540622.SGD","IE00BJJMRZ35.SGD","SG9999001176.SGD","IE0009355771.USD","LU1585245621.USD","LU2237438978.USD","LU2324357040.USD","SG9999013999.USD","IE00B19Z3581.USD","IE0002141913.USD","LU0417517546.SGD","SGXZ57979304.SGD","LU2236285917.USD","IE00BJT1NW94.SGD","LU0823416689.USD","LU2362541513.USD","LU1035775433.USD","LU1069344957.HKD","LU2456880835.USD","LU2362541273.HKD","BK4533","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD","IE0002270589.USD","IE00B19Z9P08.USD","LU1093756168.USD","BK4532","VRTX","LU0079474960.USD","SG9999001176.USD","BK4567","LU1093756325.SGD","LU0256863811.USD","BK4588","LU0109394709.USD","LU2462157665.USD","LU0432979614.USD","LU0234570918.USD","IE00BZ9MQY76.HKD","LU0889565916.HKD","IE00B894F039.SGD","BK4539","BK4139","LU2417539215.USD","LU0061475181.USD","VERA","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640907908","title":"Analysts Are Bullish on Top Healthcare Stocks: Vera Therapeutics (VERA), OrthoPediatrics (KIDS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640907908","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640907908?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:40","pubTimestamp":1780494049,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vera Therapeutics (VERA), OrthoPediatrics (KIDS) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-vera-therapeutics-vera-orthopediatrics-kids-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-vera-therapeutics-vera-orthopediatrics-kids-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4139","KIDS","BK4588","VERA","BK4539","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640942997","title":"Vera Therapeutics Aligns With FDA on Earlier Atacicept Analysis to Support Potential Full Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2640942997","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640942997?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:32","pubTimestamp":1780417939,"startTime":"0","endTime":"0","summary":"Vera Therapeutics  said Tuesday it aligned with the US Food and Drug Administration on a revised analysis plan for its phase 3 Origin trial of atacicept in adults with IgA nephropathy.The biotechnology company said estimated glomerular filtration rate results from the trial are now expected in Q3. Pending those results, Vera plans to submit a supplemental biologics license application for full approval in Q4.Vera said the FDA alignment was supported by phase 2b Origin trial results showing significant reductions in proteinuria, stabilization of kidney function and a placebo-comparable safety profile, while its phase 3 Origin trial met its primary endpoint and remains ongoing to evaluate eGFR changes.Atacicept has received FDA Breakthrough Therapy Designation for IgAN, and Vera is also studying the drug in other kidney diseases, with enrollment completed in a separate dose-ranging study, the company said.Shares of Vera Therapeutics were down more than 6% in Tuesday trading.Price: 31.76,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU2324357040.USD","LABU","BK4585","BK4588","BK4539","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640127942","title":"Vera Therapeutics announces alignment with FDA on earlier ORIGIN 3 eGFR analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2640127942","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640127942?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:27","pubTimestamp":1780417632,"startTime":"0","endTime":"0","summary":"Vera Therapeutics (VERA) announced it has aligned with the U.S. Food and Drug Administration on a revised, earlier ORIGIN 3 eGFR analysis plan to s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-announces-alignment-with-fda-on-earlier-origin-3-egfr-analysis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-announces-alignment-with-fda-on-earlier-origin-3-egfr-analysis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU2324357040.USD","BK4539","BK4585","BK4139","LABU","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640421719","title":"Raymond James sees unique buying opportunity in Vera after FDA alignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2640421719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640421719?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:26","pubTimestamp":1780417580,"startTime":"0","endTime":"0","summary":"Raymond James notes Strong Buy-rated Vera Therapeutics (VERA) announced it has alignment with FDA to carry out an earlier Phase 3 eGFR analysis to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/raymond-james-sees-unique-buying-opportunity-in-vera-after-fda-alignment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/raymond-james-sees-unique-buying-opportunity-in-vera-after-fda-alignment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","IE00B64PRP62.GBP","RJF","BK4585","LU0971096721.USD","LU1363072403.SGD","LU1804176565.USD","LU2324357040.USD","BK4539","VERA","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LABU","LU2265009873.SGD","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640838945","title":"BUZZ-U.S. STOCKS ON THE MOVE-Dollar General, Vera, Amtech Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2640838945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640838945?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:04","pubTimestamp":1780405462,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Dollar General, Vera,Amtech SystemsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL6N42A0NT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","SG9999003800.SGD","LU2462591350.SGD","LU2168564222.USD","LU1430594728.SGD","LU0094547139.USD","LU0077335932.USD","IE00B2B36J28.USD","LU0345769128.USD","LU0107464264.USD","LU0198837287.USD","LU2505996509.AUD","LU0128525929.USD","BK4538","LU0823421333.USD","LU0444971666.USD","LU2089284900.SGD","IE00BQXX3F31.USD","HK0000304797.USD","LU0289961442.SGD","LU0234572021.USD","LU1935043023.USD","LU1633808545.USD","LU2242650005.HKD","LU2394011477.USD","LU1642822529.SGD","LU0648000940.SGD","LU0048573561.USD","IE000SO60NU8.SGD","IE0001KFT4U8.USD","BK4579","BK4157","LU0786609619.USD","IE00B19Z8X17.USD","LU1868837136.USD","LU0320765059.SGD","LU1316542783.SGD","IE00BLSP4452.SGD","LU2077746001.SGD","LU0011850046.USD","LU1989772840.SGD","LU1720051108.HKD","LU0345774631.USD","LU0072461881.USD","LU0823414478.USD","LU2362541513.USD","GB00B4QBRK32.GBP","IE000BZT7R73.USD","BK4612","LU2505996681.GBP","SG9999011175.SGD","BK4122","LU0820562030.AUD","BK4515","LU2065169927.USD","LU1169590202.USD","IE00BYXW3230.USD","LU0225771236.USD","LU2213496289.HKD","IE00BMPRXQ63.HKD","LU1551013425.SGD","LU0345774391.USD","LU2290526834.HKD","LU2602419157.SGD","BK4170","LU0162691827.USD","SG9999000418.SGD","BK4533","SG9999015358.SGD","SG9999015978.USD","LU1989763427.SGD","LU0211331839.USD","LU1261432733.SGD","LU2362540622.SGD","IE00B19Z3B42.SGD","LU1116320901.HKD","LU2362541273.HKD","LU1244550577.SGD","LU1674673691.USD","LU1917777945.USD","IE00BJJMRZ35.SGD","LU1267930813.SGD","LU1670756490.USD","LU2322448957.HKD","LU0215105999.USD","LU1119994496.HKD","LU2087625088.SGD","LU2746668974.SGD","LU2430703178.SGD","SG9999015952.SGD","LU1244550221.USD","LU0690374961.EUR","LU1571399168.USD","LU0426417589.USD","SGXZ31699556.SGD","LU0157215616.USD","MRVU","LU0048584097.USD","LU0980610538.SGD","IE00B4R5TH58.HKD","ASYS","BK4592","SG9999014542.SGD","IE0002270589.USD","SGXZ81514606.USD","LU1935042991.SGD","LU0234570918.USD","LU0109391861.USD","LU2125154778.USD","LU2360107168.USD","BK4527","IE00BFTCPJ56.SGD","IE00BLSP4239.USD","SG9999017495.SGD","LU2471134796.USD","LU1066051811.HKD","LU0174119429.USD","IE000M9KFDE8.USD","LU1059921491.USD","LU1196500208.SGD","LU2102340556.USD","BK4588","LU0225284248.USD","IE000F7OJYX1.SGD","SG9999014898.SGD","LU0124676726.USD","LU0354030511.USD","MRVL","IE00BJTD4V19.USD","LU0444973449.USD","LU1629891620.HKD","LU1914381329.SGD","BK4604","LU0545039389.USD","GNRC","LU0203345920.USD","LU0109394709.USD","LU1894683348.USD","LU0496365809.HKD","LU1804176565.USD","LU0061474705.USD","LU0345768153.USD","BK4514","LU2244417387.USD","BK4581","LU0310799852.SGD","PRAX","LU2275660780.HKD","LU0889565916.HKD","LU0251142724.SGD","LU2999663052.SGD","LU0949170772.SGD","IE00BK4W5M84.HKD","BK4504","LU1803068623.USD","IE00BDCRKT87.USD","LU0006061336.USD","LU2168563687.JPY","LU2247934214.USD","LU1244550494.USD","LU1880398554.USD","LU0889566641.SGD","LU0642271901.SGD","LU1983260115.SGD","LU0256863902.USD","LU0942090050.USD","LU2473716301.USD","LU1280957306.USD","SGXZ51526630.SGD","LU0187121727.USD","IE00BJTD4N35.SGD","LU2271345857.HKD","IE00BDRTCR15.USD","IE00BD6J9T35.USD","LU1718418525.SGD","LU0130103400.USD","LU0314106906.USD","LU0472753341.HKD","LU0949170426.SGD","LU2191332357.HKD","LU0545562505.USD","LU1674673428.USD","LU0096364046.USD","LU0210533765.USD","LU1145028129.USD","IE0034235188.USD","GGLL","GOOGL","LU2125154935.USD","LU2272731865.HKD","IE0009355771.USD","LU2357305700.SGD","LU0708994859.HKD","LU1868836914.USD","LU2462157665.USD","LU2023250843.SGD","LU1366192091.USD","LU0787776722.HKD","SG9999001440.SGD","BK4566","LU0426412945.USD","GOOP","LU0267386448.USD","SG9999014906.USD","IE000MB6IJN5.SGD","LU2471134879.HKD","LU1992135472.HKD","LU2063271972.USD","IE00BHPRN162.USD","SG9999015341.SGD","LU1066053197.SGD","BK4561","LU2750360997.AUD","SG9999014880.SGD","IE00B1BXHZ80.USD","LU1066051498.USD","GOOW","LU1400636491.USD","BK4574","HK0000914686.HKD","LU2089985449.USD","LU1989764664.SGD","LU2098885051.SGD","LU2168564065.EUR","LU0689472784.USD","LU0061475181.USD","SG9999014567.USD","LU0158827948.USD","LU0316494557.USD","BK4114","GOOX","BK4532","LU0211326755.USD","LU2756315318.SGD","LU1699723380.USD","BK4141","LU0738911758.USD","BK4209","LU0175139822.USD","LU0069063385.USD","LU2360106780.USD","LU1116320737.USD","BK4550","LU0957791311.USD","LU0708995401.HKD","LU0211326839.USD","LU0306806265.USD","LU0128525689.USD","LU2326559502.SGD","IE00B19Z3581.USD","LU1815336760.USD","SHAK","LU2092627202.USD","LU0784385840.USD","IE00BWXC8680.SGD","SG9999014914.USD","LU2272731600.USD","LU0417517546.SGD","LU2168564495.EUR","BK4077","LU2403377893.USD","LU0208291251.USD","IE0034235303.USD","LU0742534661.SGD","LU1400636657.SGD","LU1585245621.USD","SARO","LU2065170008.USD","LU1951198990.SGD","LU2023250504.SGD","IE00BSNM7G36.USD","LU0354030438.USD","LU0345770308.USD","GGLS","XMTR","LU1366333091.USD","LU0225283273.USD","LU2404859667.USD","LU2462591277.SGD","BK4187","LU2168564149.EUR","LU0256863811.USD","LU2089283258.USD","LU1868836591.USD","IE00BN8TJ469.HKD","LU1506573853.SGD","LU2097344431.USD","LU2265009873.SGD","LU0466842654.USD","LU0143551892.USD","LU0661504455.SGD","LU2023250330.USD","LU1923622614.USD","LU0070217475.USD","LU1988902786.USD","LU0342679015.USD","LU0882574139.USD","IE0000B7K699.USD","LU0130518102.USD","GOU","BK4155","LU0029864427.USD","BK4529","LU0061474960.USD","LU0265550946.USD","LU0321505439.SGD","LU2023251221.USD","LU2471134523.USD","IE00BZ1G4Q59.USD","HK0000819398.USD","LU1228905540.USD","HK0000532082.HKD","LU1791710582.SGD","LU0957808578.USD","BK4573","BK4075","LU0154236417.USD","LU1670627923.USD","SG9999014575.USD","LU0265550359.USD","LU2954938101.SGD","FULC","IE00BKPKM429.USD","LU0251132253.USD","IE00B19Z8W00.USD","LU0106261372.USD","IE00BQXX3D17.EUR","LU2458330169.SGD","LU2420271590.USD","LU0994945656.USD","BK4104","LU1267930490.SGD","LU2211815571.USD","LU1201861165.SGD","LU0310800379.SGD","LU0314104364.USD","LU1232071149.USD","LU2250418816.HKD","MVLL","LU0477156797.USD","LPTH","LU0345769631.USD","IE00BMPRXR70.SGD","BK4602","BK4605","LU0203347892.USD","LU1868836757.USD","LU0302445910.USD","LU1429558221.USD","LU2028103732.USD","IE00BKDWB100.SGD","LU0823434740.USD","LU0792757196.USD","LU1861220033.SGD","IE00BKVL7J92.USD","LU0057025933.USD","LU2381873111.SGD","LU1670628061.USD","LU0672654240.SGD","LU2458330243.SGD","LU0353189680.USD","SG9999018857.SGD","BK4139","LU1303367103.USD","LU1496350171.SGD","LU1003077747.HKD","LU1551013342.USD","LU0056508442.USD","BK4576","LU1221951129.SGD","LU2756315664.SGD","LU1400636574.HKD","LU1043141396.HKD","LU0130517989.USD","LU0306807586.USD","LU1992135399.USD","LU0097036916.USD","LU1815333072.USD","IE000WAW04H5.SGD","LU2491049909.HKD","BK4147","LU1032955483.USD","IE0034235295.USD","LU2750360641.GBP","LU2054465674.USD","BK4007","LU1548497426.USD","GOOY","LU2097344357.USD","LU0976567544.SGD","LU0640476718.USD","IE00BFMHRM44.USD","LU0251131958.USD","LU0006306889.USD","LU2491050154.USD","LU0138981039.USD","LU0345768740.USD","LU1868837300.USD","LU0170899867.USD","LU2360032135.SGD","LU0158827781.USD","LU0276348264.USD","LU2092937148.SGD","LU1043141123.HKD","LU1645745479.HKD","LU2125909247.SGD","LU0211328371.USD","LU0080751232.USD","IE00BJLML261.HKD","LU2125909593.SGD","LU1935043536.SGD","LU1823568750.SGD","LU2272731782.SGD","LU1989763690.USD","SG9999014559.SGD","MCHP","LU2249611893.SGD","LU2931357623.SGD","LU1894683264.USD","LU0690374615.EUR","LU1046421795.USD","LU1201861249.SGD","LU1121112475.USD","LU1935042488.USD","LU1435385759.SGD","LU2111349929.HKD","LU0511384066.AUD","LU2471134952.CNY","LU1951200564.SGD","LU2237438978.USD","LU0321505868.SGD","LU0683600562.USD","SG9999015986.USD","LU0553294199.USD","LU0784385170.HKD","LU1202635105.USD","LU1267930730.SGD","SGXZ99366536.SGD","LU1153585028.USD","IE0004086264.USD","LU0353189763.USD","LU0868494617.USD","LU0070302665.USD","IE00B19Z9505.USD","LU0820561818.USD","LU0274383776.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","HK0000304805.HKD","LU0312595415.SGD","LU1791710400.SGD","LU2065171402.SGD","LU2592432038.USD","LU0494093205.USD","LU2433249047.HKD","LU2264538146.SGD","IE00BBT3K403.USD","IE0004091025.USD","LU1852331112.SGD","GB00B4LPDJ14.GBP","LU2491050071.SGD","BK4512","LU0820561909.HKD","LU1267930227.SGD","LU1228905037.USD","LU0289960550.SGD","LU1861215975.USD","LU2324357040.USD","LU2430703251.USD","LU0127658192.USD","LU0348723411.USD","BK4096","IE00BQXX3C00.GBP","LU0868494708.USD","LU2106854487.HKD","VERA","LU0477156953.USD","LU1989764748.USD","LU2860962120.EUR","LU0784384876.USD","LU2242649171.HKD","LU0320765489.SGD","LU1235294995.USD","LU1839511570.USD","BK4598","LU2417539215.USD","LU1064131342.USD","LU1169589451.USD","IE00BK4W5L77.USD","LU1974910355.USD","LU0557290698.USD","LU1880398471.USD","LU1221951046.USD","LU1989772923.USD","LU0310800965.SGD","LU2065171311.SGD","LU0943347566.SGD","LU1778281490.HKD","LU2322448791.USD","LU0052756011.USD","LU0345770993.USD","IE00BMPRXN33.USD","LU0096362180.USD","LU1935042215.USD","LU0689626769.HKD","LU0985320562.USD","BK4534","LU0323591593.USD","LU1301847155.USD","LU2746668461.USD","LU0289739343.SGD","LU1878469433.USD","LU2087621335.USD","LU2236285917.USD","IE0002141913.USD","LU2456880835.USD","LU0211327993.USD","LU0784383803.USD","LU1267930573.SGD","LU1923623000.USD","SG9999018865.SGD","IE00B7SZLL34.SGD","LU0823421416.USD","LU2097829019.USD","SG9999015945.SGD","PM","BK4543","LU0081259029.USD","LU2404859741.USD","HPE","LU0528227936.USD","LU1066051225.USD","BK4539","LU0476273544.USD","DG","LU0130102774.USD","BK4503","LU0985481810.HKD","HK0000914660.USD","LU0964807845.USD","RZLT","LU1084165304.USD","LU2430703095.HKD","LU1323610961.USD","LU0648001328.SGD","LU1496350502.SGD","BK4585","IE00B1XK9C88.USD","LU0823434583.USD","LU0149725797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640430529","title":"Vera Therapeutics: Buy Rating Reiterated as Atacicept’s Regulatory Path Advances; $90 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2640430529","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640430529?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:55","pubTimestamp":1780404948,"startTime":"0","endTime":"0","summary":"Vera Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Rami Katkhuda from LifeSci Capital maintain...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vera-therapeutics-buy-rating-reiterated-as-atacicepts-regulatory-path-advances-90-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vera-therapeutics-buy-rating-reiterated-as-atacicepts-regulatory-path-advances-90-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640910738","title":"Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA), Vera Therapeutics (VERA) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640910738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640910738?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:00","pubTimestamp":1780401656,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IDEAYA Biosciences (IDYA), Vera Therapeutics (VERA) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-vera-therapeutics-vera-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-vera-therapeutics-vera-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541513.USD","BK4581","LU0823416689.USD","LU0823434740.USD","LU2237438978.USD","LU0289739699.SGD","BK4137","LU0823434583.USD","LU0053666078.USD","HCSG","LU0882574055.USD","LU0320765992.SGD","LU2362541273.HKD","LU2324357040.USD","VERA","BK4588","LU2023250504.SGD","LU0058720904.USD","LU0109394709.USD","LU0114720955.EUR","BK4539","LU2468319806.SGD","LU0889565916.HKD","LU0128526141.USD","LU1917777945.USD","LU2362540622.SGD","LU1974910355.USD","LU2106854487.HKD","LU2089984988.USD","LABU","XLV","REGN","IDYA","BK4585","XBI","BK4139","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640591059","title":"Vera Therapeutics Advances Atacicept Approval Path in IgA Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2640591059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640591059?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:37","pubTimestamp":1780400231,"startTime":"0","endTime":"0","summary":"The latest update is out from Vera Therapeutics ( ($VERA) ). On June 2, 2026, Vera Therapeutics, Inc. announced it had reached agreement with the U...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-advances-atacicept-approval-path-in-iga-nephropathy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-advances-atacicept-approval-path-in-iga-nephropathy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","LU2324357040.USD","BK4139","VERA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640815910","title":"BUZZ-Vera rises as FDA agrees to review late-stage kidney drug data for full approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2640815910","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640815910?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:36","pubTimestamp":1780400167,"startTime":"0","endTime":"0","summary":"BUZZ-Vera rises as FDA agrees to review late-stage kidney drug data for full approval** Shares of Vera Therapeutics VERA.O rise 2.9% to $34.92 premarket ** VERA says it has aligned with the U.S. Food and Drug Administration to speed up plans that could lead to full approval of its experimental kidney disease drug, atacicept** Says the FDA has agreed to review key data from a late-stage study earlier than planned, with results now expected in Q3 2026, instead of 2027** Vera plans to apply for supplemental application in Q4 based on additional trial data** Atacicept is already under review by the FDA for accelerated approval in patients with IgA Nephropathy, with a decision expected on July 7** IgA nephropathy is an autoimmune condition that can lead to kidney failure** Up to last close, stock down about 33% YTD   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL4N42A0YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4539","LU2324357040.USD","VERA","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640878917","title":"Vera Therapeutics pulls forward ORIGIN phase 3 eGFR analysis of atacicept in IgA nephropathy to Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640878917","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640878917?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:03","pubTimestamp":1780398238,"startTime":"0","endTime":"0","summary":"Vera Therapeutics aligned with the FDA to pull forward a key Phase 3 kidney-function analysis for atacicept in IgA nephropathy to Q3 2026.Results will be presented in the future; the earlier readout is intended to support a path to full approval if outcomes are positive.Prior ORIGIN Phase 3 interim results were already presented, showing the trial met its primary goal with a clinically meaningful improvement versus placebo.Pending the Q3 2026 readout, a supplemental BLA is planned for Q4 2026, targeting potential full approval in 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL6954DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2324357040.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","IE00BN0W2W23.USD","BK4585","LU0314104364.USD","VERA","LU2210149790.SGD","BK4112","LU2095319765.USD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4139","IE00B3QW5Z07.USD","BK4539","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640912786","title":"Vera Therapeutics, - Revised Origin 3 Egfr Analysis Planned for Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640912786","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640912786?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUABB3HJY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VERA","BK4139","BK4588","BK4585","BK4539","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640912735","title":"Vera Therapeutics Announces Alignment With U.S. FDA on Earlier Origin Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults With Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2640912735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640912735?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUABB3HJY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","VERA","BK4585","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.veratx.com","stockEarnings":[{"period":"1week","weight":0.1542},{"period":"1month","weight":0.1794},{"period":"3month","weight":0.0422},{"period":"6month","weight":-0.2441},{"period":"1year","weight":0.7375},{"period":"ytd","weight":-0.2002}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":-0.0217},{"period":"3month","weight":0.158},{"period":"6month","weight":0.0637},{"period":"1year","weight":0.2095},{"period":"ytd","weight":0.0768}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.057587},{"month":2,"riseRate":0.4,"avgChangeRate":0.015839},{"month":3,"riseRate":0.4,"avgChangeRate":-0.047765},{"month":4,"riseRate":0,"avgChangeRate":-0.103447},{"month":5,"riseRate":0.2,"avgChangeRate":-0.049498},{"month":6,"riseRate":0.5,"avgChangeRate":0.160453},{"month":7,"riseRate":0.8,"avgChangeRate":0.137629},{"month":8,"riseRate":0.6,"avgChangeRate":0.019112},{"month":9,"riseRate":0.6,"avgChangeRate":0.088867},{"month":10,"riseRate":0.2,"avgChangeRate":-0.071412},{"month":11,"riseRate":0.8,"avgChangeRate":0.292871},{"month":12,"riseRate":0.6,"avgChangeRate":0.07812}],"exchange":"NASDAQ","name":"Vera Therapeutics, Inc.","nameEN":"Vera Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vera Therapeutics, Inc.(VERA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vera Therapeutics, Inc.,VERA,Vera Therapeutics, Inc.股票,Vera Therapeutics, Inc.股票老虎,Vera Therapeutics, Inc.股票老虎国际,Vera Therapeutics, Inc.行情,Vera Therapeutics, Inc.股票行情,Vera Therapeutics, Inc.股价,Vera Therapeutics, Inc.股市,Vera Therapeutics, Inc.股票价格,Vera Therapeutics, Inc.股票交易,Vera Therapeutics, Inc.股票购买,Vera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vera Therapeutics, Inc.(VERA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}